產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-CESK1抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢(xún)訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-CESK1抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-CESK1
Cat. Number:
Anti-CESK1抗體KL-6406R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
CESK1, also known as CCT8L2 (chaperonin containing TCP1, subunit 8 theta-like 2), is a 557 amino acid protein that Anti-CESK1抗體localizes to the cytoplasm and is thought to function as a molecular chaperone, possibly assisting protein folding after ATP hydrolysis. CESK1 belongs to the TCP-1 chaperonin family and is encoded by a gene which maps to human chromosome 22. Mutations in several of the genes that map to chromosome 22 are involved in the development of Phelan-McDermid syndrome, neurofibromatosis type 2, autism and schizophrenia. Additionally, translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia chromosome and the subsequent production of the novel fusion protein Bcr-Abl, a potent cell proliferation activator found in several types of leukemias.
Also known as:
CCT8L2; KCNMB3L; T Anti-CESK1抗體complex protein 1; CESK1; chaperonin containing TCP1, subunit 8 (theta)-like 2; Putative T-complex protein 1 subunit theta-like 2; T complex protein 1; chaperonin containing TCP1, subunit 8 theta-like 2; TCPQM_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, .
●
Immunogen: KLH conjugated synthetic peptide derived from human CESK1 (509-557aa).
●
Predicted Molecular Anti-CESK1抗體Weight: 59kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 Anti-CESK1抗體 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl006Eq01 雙調(diào)蛋白(AREG)多克隆抗體 Polyclonal Antibody to Amphiregulin (AREG)
kl006Ga01 雙調(diào)蛋白(AREG)多克隆抗體 Polyclonal Antibody to Amphiregulin (AREG)
kl006Hu01 雙調(diào)蛋白(AREG)多克隆抗體 Polyclonal Antibody to Amphiregulin (AREG)
kl006Mu01 雙調(diào)蛋白(AREG)多克隆抗體 Polyclonal Antibody to Amphiregulin (AREG)
kl006Po01 雙調(diào)蛋白(AREG)多克隆抗體 Polyclonal Antibody to Amphiregulin (AREG)
kl006Ra01 雙調(diào)蛋白(AREG)多克隆抗體 Polyclonal Antibody to Amphiregulin (AREG)
kl006Rb51 雙調(diào)蛋白(AREG)多克隆抗體 Polyclonal Antibody to Amphiregulin (AREG)
kl007Bo01 血管生長(zhǎng)素(ANG)多克隆抗體 Polyclonal Antibody to Angiogenin (ANG)
kl007Eq01 血管生長(zhǎng)素(ANG)多克隆抗體 Polyclonal Antibody to Angiogenin (ANG)
kl007Hu01 血管生長(zhǎng)素(ANG)多克隆抗體 Polyclonal Antibody to Angiogenin (ANG)
kl007Mu01 血管生長(zhǎng)素(ANG)多克隆抗體 Polyclonal Antibody to Angiogenin (ANG)
kl007Po01 血管生長(zhǎng)素(ANG)多克隆抗體 Polyclonal Antibody to Angiogenin (ANG)
kl007Ra01 血管生長(zhǎng)素(ANG)多克隆抗體 Polyclonal Antibody to Angiogenin (ANG)
kl008Bo01 血管生成素1(ANGPT1)多克隆抗體 Polyclonal Antibody to Angiopoietin 1 (ANGPT1)
kl008Ca01 血管生成素1(ANGPT1)多克隆抗體 Polyclonal Antibody to Angiopoietin 1 (ANGPT1)
kl008Ga01 血管生成素1(ANGPT1)多克隆抗體 Polyclonal Antibody to Angiopoietin 1 (ANGPT1)
kl008Hu01 血管生成素1(ANGPT1)多克隆抗體 Polyclonal Antibody to Angiopoietin 1 (ANGPT1)
kl008Mu01 血管生成素1(ANGPT1)多克隆抗體 Polyclonal Antibody to Angiopoietin 1 (ANGPT1)
kl008Po01 血管生成素1(ANGPT1)多克隆抗體 Polyclonal Antibody to Angiopoietin 1 (ANGPT1)
